<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">Recurrent disease</z:e> following complete cytoreductive surgery (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e>) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a relevant clinical scenario </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to determine risk factors for recurrence </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Prospectively collected data of patients enrolled in the Peritoneal Surface <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Malignancy</z:e> Program at the University of Tübingen between 2005 and 2011 were retrospectively analyzed </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were treated by standardized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e> and HIPEC </plain></SENT>
<SENT sid="4" pm="."><plain>Recurrence was defined either radiographically by CT, PET-CT scan, or reoperation </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Fifty-two patients received complete <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e> (CC-0/CC-1) and HIPEC </plain></SENT>
<SENT sid="6" pm="."><plain>Median time to recurrence was 229 days (103-1,028) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall recurrence rate within follow-up was 48 % </plain></SENT>
<SENT sid="8" pm="."><plain>Of patients with <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e>, 44 % experienced extraperitoneal systemic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> spread </plain></SENT>
<SENT sid="9" pm="."><plain>In multivariate analysis, grading of ≥3 was shown as an independent risk factor for <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e>, while a trend was observed for maximal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> load in the upper abdominal region </plain></SENT>
<SENT sid="10" pm="."><plain>Clinical parameters did not show an impact on recurrence </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">Primary tumor</z:e> grading seems to be an independent risk factor for recurrence following complete <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e> and HIPEC in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>-derived peritoneal surface <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
</text></document>